Skip to content

ACOPHAR

Absorbed by VDG PHARMA KBO/BCE: BE 0469.749.422

Mandates through the years

1 name
VDG PHARMA
Sole director
Earliermandate already running before its first mention
Mandates as a list
  • VDG PHARMA
    • Sole director, until 20-10-2020

Control

Shareholder
This company
ACOPHAR
Equity €592,085
Loss €1,179 in 2020

Capital

Capital
€6,197.33
Shares
750
Contribution per share
€8.26
Equity per share
€789 in 2020
Source
2020 annual accounts

Shareholders

Capital transactions

Shareholders according to the deeds
Stated in the deed deed of 24-07-2020 ↗
Capital over time
  1. 24-07-2020 Capital stated in the deed · €18,592.01 · 750 shares

Office holders in the KBO →

Next steps